Delivery Order SPE2DB20D1109-SPE2DB25FP58J
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Valtoco 5 mg nasal spray, with a ceiling value of $1,126.10 and a firm fixed price contract type. This delivery order, which is expected to be completed by August 11, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order contract valued at $1,126.10 to AmerisourceBergen Drug Corp for the supply of Valtoco 5 mg nasal sprays. This firm fixed-price, non-set-aside delivery order was awarded on June 12, 2025, with an ultimate completion date of June 13, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,385.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, with an ultimate completion date of August 15, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The delivery order contains no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $3,106.66 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal spray, with an ultimate completion date of September 15, 2025. This competitive award (no set-aside used) represents a firm fixed-price delivery order executed on September 12, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a naloxone nasal spray used for emergency treatment of opioid...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of September 3, 2025. This firm fixed-price contract, awarded on September 2, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Valtoco is a naloxone nasal spray formulation used for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays under a firm fixed-price contract with a ceiling value of $1,126.10. The order was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its Corporate Office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,259.24 firm fixed-price delivery order for Valtoco 10 mg nasal sprays on September 28, 2025, with completion scheduled for September 29, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on September 11, 2025, with a ceiling value of $3,388.86. This firm fixed-price delivery order, which has no set-aside designation, represents a competitively awarded procurement supporting federal medical supply requirements. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025....
- The Defense Logistics Agency awarded a $1,129.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be performed at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,300.40 on August 14, 2025, for the supply of Valtoco 10 mg nasal sprays, with an ultimate completion date of August 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP58JDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $1,129.62. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. Valtoco is a naloxone nasal spray used for emergency treatment of opioid overdose, reflecting the critical role AmerisourceBergen plays in supporting military and federal healthcare system pharmaceutical needs. As a major pharmaceutical distributor, the company maintains a comprehensive portfolio of medications and medical supplies serving the Defense Health Agency, U.S. Coast Guard, and other government health systems through its prime vendor agreement with DLA. This delivery order exemplifies the routine pharmaceutical replenishment cycles conducted under AmerisourceBergen's global pharmaceutical support vehicle, which enables flexible procurement of specialty medications, generic drugs, and medical supplies across multiple therapeutic domains to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/15/25 |